With the analysis among 19,630 patents, we discovered top 459 key players by total patent application. Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc. are dominant in this area. They take 10.36% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 824
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 458
New York, United States
Patent: 426
California, United States
Patent: 422
California, United States
Patent: 375
Basel-Stadt, Switzerland
Patent: 358
New York, United States
Patent: 322
Tokyo-to, Japan
Patent: 308
With the analysis among 697 patents, we discovered top 80 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, DRAGONFLY Therapeutics, Inc., Orum Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 76
Washington, United States
Patent: 36
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 32
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 31
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 22
Huadao (Shanghai) Biomedical Co., Ltd.
Shanghai Shi, China
Patent: 19
With the analysis among related 7,136 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Janssen Biotech, F. Hoffmann-La Roche Ltd. take 6.45% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 181
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 130
Akeso Biopharma Co., Ltd.
Guangdong Sheng, China
Patent: 114
New York, United States
Patent: 105
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 77
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 76
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 76
California, United States
Patent: 73
With the analysis among related 7,136 patents in last 5 years, we discover 211 new entrants. DRAGONFLY Therapeutics, Inc., Dongguan Pengzhi Biotechnology Co., Ltd., WuXi Biologics Ireland Ltd. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 76
Dongguan Pengzhi Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 46
WuXi Biologics Ireland Ltd.
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 31
Telix International Pty Ltd
undefined undefined
Patent: 22
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 22
Tayu Huaxia Biotech Medical Group Co., Ltd.
Beijing Shi, China
Patent: 18
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 17
Hefei TG ImmunoPharma Co., Ltd
Anhui Sheng, China
Patent: 17
With the analysis among 3,854 patents, we discovered top 231 universities and scientific research institutions by total patent application. Nanchang University, Fourth Military Medical University, Vrije Universiteit Brussel are dominant in this area. They take 9.52% of the total patent filing.
Jiangxi Sheng, China
Patent: 93
Fourth Military Medical University
Hunan Sheng, China
Patent: 72
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 70
Pontificia Universidad Católica de Chile
The Scripps Research Institute
California, United States
Patent: 48
Tennessee, United States
Patent: 45
Zhejiang Sheng, China
Patent: 45
Academy of Military Medical Sciences
Shanghai Jiao Tong University
Shanghai Shi, China
Patent: 35
North Carolina, United States
Patent: 34